Study guide

14.2 The Difficult Airway: Assessment, Algorithms, and Rescue Oxygenation

EDAIC Part I European Diploma in Anaesthesiology and Intensive Care

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: The EDAIC Part I Examination

1.1 EDAIC Part I Exam Format, Scoring and Multiple True/False Strategy

2 Chapter 2: Anatomy for Anaesthesia and Intensive Care

2.1 Functional Anatomy of the Upper Airway, Larynx, and Tracheobronchial Tree 2.2 Neuraxial Anatomy: Spine, Spinal Cord, Meninges, and Spaces 2.3 Vascular Anatomy for Central and Peripheral Cannulation 2.4 Peripheral Nerve Plexuses and Autonomic Nervous System Pathways 2.5 Thoracic Anatomy: Chest Wall, Intercostal Spaces, Pleura, Mediastinum and Heart

3 Chapter 3: Respiratory and Cardiovascular Physiology

3.1 Respiratory Mechanics, Lung Volumes, and Work of Breathing 3.2 Ventilation-Perfusion Relationships, Shunt, and Gas Exchange 3.3 Control of Breathing, Hypoxia, Altitude and Hyperbaric Physiology 3.4 Cardiac Cycle, Electrophysiology, and Ventricular Function 3.5 Vascular Resistance, Microcirculation, and Systemic Hemodynamics

4 Chapter 4: Neurophysiology, Renal, Hepatic and Acid-Base Physiology

4.1 Cerebral Blood Flow, Intracranial Pressure, and CSF Dynamics 4.2 Renal Physiology, Glomerular Filtration, and Tubular Transport 4.3 Hepatic Blood Flow, Metabolism, and Clearance 4.4 Acid-Base Regulation, Buffering Systems, and Stewart Approach

5 Chapter 5: Endocrine and Haematological Physiology

5.1 Endocrine Physiology and the Neuroendocrine Stress Response 5.2 Haemostasis Physiology, Coagulation Testing and Inherited Bleeding Disorders

6 Chapter 6: Special Patient Physiology: Maternal, Paediatric and Geriatric

6.1 Maternal Physiological Adaptations to Pregnancy and Uteroplacental Flow 6.2 Neonatal and Paediatric Physiological Differences 6.3 Physiological Changes of Ageing and Thermoregulation

7 Chapter 7: General Pharmacological Principles and Inhalational Anaesthetics

7.1 Pharmacokinetic Principles, Compartmental Models, and Clearance 7.2 Pharmacodynamic Mechanisms, Receptor Theory, and Drug Interactions 7.3 Physical Properties, Uptake, and Distribution of Volatile Anaesthetics 7.4 Minimum Alveolar Concentration (MAC), Organ Effects, and Toxicity

8 Chapter 8: Intravenous Agents, Neuromuscular Blockade and Analgesics

8.1 Intravenous Induction Agents: Propofol, Etomidate, Ketamine, and Barbiturates 8.2 Neuromuscular Blocking Agents: Depolarizing and Non-Depolarizing Drugs 8.3 Neuromuscular Monitoring and Reversal: Anticholinesterases and Sugammadex 8.4 Opioid Pharmacology, Receptors, and Non-Opioid Analgesic Agents

9 Chapter 9: Cardiovascular Drugs, Autonomic Pharmacology and Local Anaesthetics

9.1 Inotropes, Vasopressors, and Inodilators in Perioperative Care 9.2 Antiarrhythmic, Antihypertensive, and Beta-Adrenergic Antagonist Drugs 9.3 Local Anaesthetic Pharmacology, Toxicity (LAST), and Lipid Emulsion Therapy

10 Chapter 10: Haematological and Internal Medicine Pharmacology

10.1 Anticoagulant, Antiplatelet and Haemostatic Drugs and Their Reversal 10.2 Internal Medicine Drugs: Endocrine, Respiratory, Psychiatric and Antiepileptic Agents and Their Anaesthetic Interactions

11 Chapter 11: Physics, Clinical Measurement and Medical Equipment

11.1 Physical Gas Laws, Fluid Dynamics, and Resistance Principles 11.2 Anaesthetic Machines, Gas Supply Pipelines, Cylinders, and Safety Mechanisms 11.3 Breathing Systems, Vaporizer Mechanics, and Scavenging Systems 11.4 Invasive and Non-Invasive Hemodynamic and Respiratory Monitoring

12 Chapter 12: Electrical Safety, Temperature, Humidity and Gas Analysis

12.1 Electricity, Electrical Safety, Diathermy, Defibrillation, Implanted Devices and Fire 12.2 Temperature Measurement, Humidity, Gas Analysis and SI Units

13 Chapter 13: Biostatistics, Clinical Trials and Evidence Appraisal

13.1 Descriptive Statistics, Distributions, and Parametric vs Non-Parametric Tests 13.2 Hypothesis Testing, Power, Type I/II Errors, and Confidence Intervals 13.3 Clinical Study Designs, Bias, and Diagnostic Test Performance (Sensitivity, Specificity, ROC)

14 Chapter 14: General Anaesthesia, Preoperative Evaluation and Airway Management

14.1 Preoperative Risk Assessment, Cardiovascular Risk Indices, and Fasting Guidelines 14.2 The Difficult Airway: Assessment, Algorithms, and Rescue Oxygenation 14.3 Intraoperative Fluid Therapy, Goal-Directed Hemodynamics, and Blood Conservation 14.4 Post-Anaesthesia Care Unit (PACU) Management, Emergence, and Postoperative Nausea/Vomiting

15 Chapter 15: Coexisting Disease and Preoperative Investigations

15.1 Interpreting Investigations: ECG, Chest Radiograph, Lung Function and Blood Tests 15.2 Coexisting Disease I: Asthma, COPD, Obstructive Sleep Apnoea, Obesity, Liver and Renal Disease 15.3 Endocrine Disease and Emergencies: Diabetes, DKA and HHS, Thyroid, Adrenal, Phaeochromocytoma and Carcinoid 15.4 Coexisting Disease II: Neuromuscular and Neurological Disease

16 Chapter 16: Subspecialty Anaesthesia: Cardiothoracic, Vascular and Neuroanaesthesia

16.1 Anaesthesia for Cardiac Surgery and Cardiopulmonary Bypass Management 16.2 Thoracic Anaesthesia, One-Lung Ventilation, and Major Vascular Surgery 16.3 Neuroanaesthesia: Craniotomy, Sitting Position, and Traumatic Brain Injury

17 Chapter 17: Obstetric, Paediatric and Ambulatory Anaesthesia

17.1 Obstetric Analgesia and Anaesthesia: Labour, Caesarean Delivery, and High-Risk Conditions 17.2 Paediatric Anaesthesia: Induction, Airway Management, and Emergencies 17.3 Ambulatory Day-Surgery Selection, Premedication, and Elderly Patient Anaesthesia

18 Chapter 18: Anaesthetic Complications and Specialty Settings

18.1 Anaesthetic Complications: Accidental Awareness, Aspiration, Positioning Injuries, Visual Loss and Dental Damage 18.2 Anaesthesia for ENT and Laser Airway Surgery, Ophthalmic Surgery, and Laparoscopic and Robotic Surgery

19 Chapter 19: Regional Anaesthesia and Acute/Chronic Pain Management

19.1 Neuraxial Techniques: Spinal, Epidural, and Caudal Anaesthesia 19.2 Upper and Lower Limb Peripheral Nerve and Fascial Plane Blocks 19.3 Multimodal Acute Postoperative Pain Management and ERAS Pathways 19.4 Chronic and Neuropathic Pain Syndromes and Interventional Management 19.5 Palliative Symptom Control, Psychological Aspects of Pain and Multidisciplinary Pain Management

20 Chapter 20: Intensive Care Medicine: Ventilation, Shock and Organ Support

20.1 Acute Respiratory Distress Syndrome (ARDS) and Mechanical Ventilation Strategies 20.2 Sepsis-3 Definitions, Septic Shock, and Hemodynamic Resuscitation 20.3 Acute Kidney Injury, Indications for Dialysis, and Continuous Renal Replacement Therapy 20.4 ICU Sedation, Delirium, Weaning, and Brain Death Determination

21 Chapter 21: Intensive Care Medicine: Admission, Nutrition, Infection and Electrolytes

21.1 ICU Admission, Severity Scoring, Nutrition and Routine Prophylaxis 21.2 Antimicrobial Therapy, Stewardship and ICU-Acquired Infections 21.3 Electrolyte Disorders: Sodium, Potassium, Calcium, Magnesium and Phosphate

22 Chapter 22: Intensive Care and Emergency Medicine: Neurocritical Care, Poisoning and Cardiorespiratory Emergencies

22.1 Neurocritical Care: Subarachnoid Haemorrhage, Stroke, Status Epilepticus and Acute Neuromuscular Failure 22.2 Acute Poisoning: Toxidromes, Decontamination and Specific Antidotes 22.3 Acute Cardiorespiratory Emergencies: Pulmonary Embolism, Acute Severe Asthma and COPD, Non-Invasive Support and Acute Heart Failure

23 Chapter 23: Resuscitation, Perioperative Emergencies and Professional Ethics

23.1 Advanced Life Support (ALS) Guidelines and Perioperative Cardiac Arrest 23.2 Perioperative Crises: Malignant Hyperthermia and Severe Anaphylaxis 23.3 Major Trauma, Hemorrhagic Shock, and Massive Transfusion Protocols 23.4 Professional Ethics, Informed Consent, Patient Safety, and Helsinki Declaration

24 Chapter 24: Newborn, Paediatric and Obstetric Emergencies

24.1 Newborn Life Support and Paediatric Life Support 24.2 Obstetric Emergencies: Maternal Collapse, Amniotic Fluid Embolism, Uterine Inversion and Resuscitative Hysterotomy

25 Chapter 25: Burns, Environmental Emergencies and Patient Transport

25.1 Burns, Inhalation Injury, Drowning, Hypothermia, Heat Illness and Decompression Illness 25.2 Prehospital Care and Intra- and Inter-Hospital Transport of the Critically Ill

14.2 The Difficult Airway: Assessment, Algorithms, and Rescue Oxygenation

Key Takeaways Explain This Topic AI

Bedside airway evaluation requires a multimodal combination of anatomical indicators: Modified Mallampati classification (Classes I-IV), thyromental distance ( < 6.0 − 6.5 cm <6.0-6.5\text{ cm} < 6.0 − 6.5 cm ), sternomental distance ( < 12.5 cm <12.5\text{ cm} < 12.5 cm ), inter-incisor opening ( < 3 − 4 cm <3-4\text{ cm} < 3 − 4 cm ), and Upper Lip Bite Test (ULBT Class III).

The Cormack-Lehane classification grades direct laryngoscopic glottic exposure: Grade 1 (entire vocal cords visible), Grade 2a (partial cords), Grade 2b (arytenoids/posterior cords only), Grade 3 (epiglottis only), and Grade 4 (neither glottis nor epiglottis visible).

The Difficult Airway Society 2025 guideline keeps a sequential four-plan structure: Plan A (tracheal intubation, with videolaryngoscopy recommended, maximum 3 + 1 attempts), Plan B (second-generation supraglottic airway, maximum 3 attempts), Plan C (final two-person facemask ventilation with full neuromuscular block while preparing front-of-neck access), and Plan D (emergency front-of-neck access, eFONA).

In a 'Can't Intubate, Can't Oxygenate' (CICO) crisis (Plan D), DAS recommends the scalpel-bougie-tube technique: a vertical skin incision, horizontal stab through the cricothyroid membrane, 90 ∘ 90^\circ 9 0 ∘ blade rotation, coudé-tip bougie insertion, and railroading a cuffed 6.0 mm 6.0\text{ mm} 6.0 mm tracheal tube; needle cricothyroidotomy and jet ventilation carry an unacceptably high failure rate ( > 60 % >60\% > 60% ) and severe barotrauma risks.

Awake Tracheal Intubation (ATI) remains the primary technique for anticipated difficult airway management; it requires psychological preparation, antisialogogues (glycopyrrolate), targeted mucosal topicalization with lidocaine (maximum safe dose ≤ 9 mg/kg \le 9\text{ mg/kg} ≤ 9 mg/kg lean body weight), airway nerve blocks (superior laryngeal and glossopharyngeal), and titrated conscious sedation (remifentanil TCI or dexmedetomidine) maintaining spontaneous ventilation.

Last updated: October 2026

14.2 The Difficult Airway: Assessment, Algorithms, and Rescue Oxygenation

Airway management is the defining competence of anaesthesiology. Unanticipated difficult tracheal intubation and failure to oxygenate remain major contributors to permanent hypoxic brain injury and perioperative mortality. Preventing catastrophic outcomes mandates systematic bedside airway assessment, strict adherence to cognitive rescue algorithms, and rapid execution of emergency front-of-neck access.

1. Bedside Airway Examination and Multimodal Risk Indices

No single bedside test possesses sufficient sensitivity and specificity to predict a difficult airway in isolation. Clinicians must perform a multimodal battery of anatomical assessments. [ MULTIMODAL AIRWAY EVALUATION ]

  • |
  • +---------------------------+---------------------------+
  • | | |
  • [ Oropharyngeal View ] [ Anatomical Distances ] [ Mandibular Mobility ]
  • Modified Mallampati • Thyromental (< 6.0 cm) • Upper Lip Bite Test
  • (Classes I to IV) • Sternomental (< 12.5 cm) (Class I, II, III)
  • Inter-incisor (< 3.0 cm) • Cervical spine extension
  • The Modified Mallampati Classification (Samsoon & Young)

Assessed with the patient sitting upright, head in neutral position, mouth opened maximally, and tongue protruded without phonation (phonation causes reflex contraction of the palatopharyngeus muscle, deceptively elevating the soft palate):

Class I: Soft palate, fauces, uvula, anterior and posterior tonsillar pillars visible.

Class II: Soft palate, fauces, and uvula visible (pillars obscured by tongue base).

Class III: Soft palate and base of uvula visible.

Class IV: Only the hard palate is visible; soft palate is completely obscured.

Clinical Correlation: Classes III and IV correlate with poor glottic visualization during direct laryngoscopy (Cormack-Lehane Grades 3 and 4).

Anatomical Distances and Mandibular Protrusion

Thyromental Distance (Patil's Test): Measured along a straight line from the thyroid notch to the lower border of the mandibular mentum with the neck fully extended. A distance < 6.0 − 6.5 cm < 6.0-6.5\text{ cm} < 6.0 − 6.5 cm (or < 3 <3 < 3 fingerbreadths) indicates a receding mandible or an anterior larynx, providing insufficient space for the tongue to be displaced by the laryngoscope blade into the submandibular space.

Sternomental Distance: Distance from the superior border of the manubrium sterni to the tip of the mentum with full neck extension. A distance < 12.5 cm < 12.5\text{ cm} < 12.5 cm indicates restricted cervical spine mobility and a short neck.

Inter-Incisor Distance (Mouth Opening): Distance between the incisive edges of the upper and lower teeth with maximum active mouth opening. Normal is > 4.0 cm >4.0\text{ cm} > 4.0 cm . A distance < 3.0 − 3.5 cm < 3.0-3.5\text{ cm} < 3.0 − 3.5 cm ( < 2 <2 < 2 fingerbreadths) restricts insertion of standard rigid laryngoscope blades and supraglottic airway devices.

Upper Lip Bite Test (ULBT): Evaluates mandibular range of motion and subluxation:

Class I: Lower incisors can bite the upper lip above the vermilion border.

Class II: Lower incisors can bite the upper lip below the vermilion border.

Class III: Lower incisors cannot reach or bite the upper lip.

Significance: ULBT Class III is an exceptionally strong independent predictor of difficult direct laryngoscopy.

Cervical Spine Mobility (Atlanto-Occipital Extension): Normal atlanto-occipital extension is ≥ 35 ∘ \ge 35^\circ ≥ 3 5 ∘ . A reduction of > 80 % >80\% > 80% of normal mobility prevents alignment of the oral, pharyngeal, and laryngeal visual axes.

Comprehensive Difficult Airway Mnemonics

LEMON Law (Difficult Laryngoscopy): L ook externally (facial trauma, retrognathia, beard); E valuate the 3-3-2 rule ( 3 3 3 fingers mouth opening, 3 3 3 fingers hyomental distance, 2 2 2 fingers hyoid-thyroid distance); M allampati class; O bstruction / Obesity; N eck mobility.

MOANS (Difficult Bag-Mask Ventilation): M ask seal (beards, craniofacial deformity); O besity / Obstruction; A ge > 55 years >55\text{ years} > 55 years ; N o teeth (edentulous face causes sunken cheeks); S tift lungs / Sleep apnoea.

RODS (Difficult Supraglottic Airway): R estricted mouth opening; O bstruction at glottic/subglottic level; D isrupted or distorted airway; S tiff lungs or cervical spine.

  • Assessment Test High-Risk Threshold Anatomical / Physiological Mechanism
  • Modified Mallampati Class III or IV Disproportionately large tongue relative to oropharyngeal cavity

Thyromental Distance < 6.0 cm < 6.0\text{ cm} < 6.0 cm Small submandibular space; tongue cannot be displaced anteriorly

Sternomental Distance < 12.5 cm < 12.5\text{ cm} < 12.5 cm Impaired cervical spine extension; inability to align visual axes

Inter-Incisor Distance < 3.0 cm < 3.0\text{ cm} < 3.0 cm Line-of-sight obstruction; inability to insert blade or supraglottic device

  • Upper Lip Bite Test Class III Restricted mandibular subluxation; fixed overbite
  • 2. Laryngoscopic Grading: Cormack-Lehane vs POGO Score

During laryngoscopy, the visual field is systematically documented using standardized grading systems. [ CORMACK-LEHANE LARYNGOSCOPY GRADES ]

  • Grade 1 Grade 2a Grade 2b Grade 3 Grade 4
  • (Full) (Partial) (Arytenoids) (Epiglottis) (No Glottis)
  • /--\ /--\ /--\ /--\ /--\
  • | /\ | | | | | | == | | |
  • | || | | /\ | | .. | | | | |
  • | \/ | | \/ | | \/ | | | | |
  • \--/ \--/ \--/ \--/ \--/
  • Full glottis Posterior cords Arytenoids only Epiglottis only Soft palate only
  • The Modified Cormack-Lehane System (Yentis & Lee)

Grade 1: Complete visualization of the vocal cords, glottic aperture, and anterior commissure.

Grade 2a: Partial visualization of the vocal cords (posterior cord structures visible).

Grade 2b: Visualization of the arytenoid cartilages and posterior glottic rim only; no vocal cords visualized.

Grade 3: Visualization of the epiglottis only; no glottic aperture or arytenoids seen.

Grade 4: Neither the epiglottis nor the glottis can be visualized; only the soft palate is seen.

Critical Distinction: Grade 2a typically permits straightforward intubation using a standard curved blade. In contrast, Grade 2b represents a difficult intubation requiring a gum-elastic bougie or videolaryngoscope. Grade 3 requires an angled videolaryngoscope or bougie guidance. Grade 4 indicates extreme anatomical difficulty.

Percentage of Glottic Opening (POGO) Score

The POGO score represents the linear percentage of the glottic aperture visualized between the anterior commissure ( 100 % 100\% 100% ) and the posterior interarytenoid notch ( 0 % 0\% 0% ). A Cormack-Lehane Grade 1 view corresponds to a POGO of 100 % 100\% 100% and Grades 3 and 4 to a POGO of 0 % 0\% 0% ; Grade 2 views span intermediate values, so POGO discriminates partial views more finely and has better inter-observer reliability.

Direct versus Videolaryngoscopy

Videolaryngoscopes employ a miniature CMOS camera at the blade tip, projecting the image onto an external monitor. They are broadly divided into:

Standard Geometry Blades (Macintosh-style): Allows both direct line-of-sight view and indirect screen visualization. Tracheal tubes are inserted using a standard curved stylet or bougie.

Hyperangulated Blades (e.g., GlideScope, McGrath X-Blade, C-MAC D-Blade): Possess an acute 60 ∘ 60^\circ 6 0 ∘ anterior curvature. These look "around the corner" of the tongue base without requiring alignment of the oral, pharyngeal, and laryngeal axes. Crucial Rule: Intubating with a hyperangulated blade strictly requires a rigid stylet matching the acute curve of the blade; the tube is guided into the glottis under indirect video viewing.

3. The DAS 2025 Difficult Airway Guideline

The Difficult Airway Society (DAS) 2025 guideline for unanticipated difficult airway management in adults (Ahmad et al., British Journal of Anaesthesia , published online November 2025) replaced the 2015 version. It keeps the sequential Plans A to D but strengthens several points: videolaryngoscopy should be used for tracheal intubation; oxygenation is maintained throughout, including head-up preoxygenation and nasal oxygen during airway attempts; intubation attempts are limited to three plus one by a more experienced operator; blind intubation through a supraglottic airway device is not recommended; waveform capnography confirms every airway; and preparation for front-of-neck access starts early. [ DAS 2025 RESCUE SEQUENCE (SIMPLIFIED) ]

  • [ PLAN A: Tracheal Intubation ]
  • Videolaryngoscopy, optimal position, continuous oxygenation
  • External laryngeal manipulation + bougie / stylet
  • MAXIMUM 3 ATTEMPTS (+1 by a more experienced operator)
  • |
  • v (Failed Intubation)
  • [ PLAN B: Oxygenate via Supraglottic Airway (SAD) ]
  • 2nd-Generation SAD with Gastric Drainage (i-gel, ProSeal)
  • MAXIMUM 3 ATTEMPTS
  • If successful: STOP & THINK (wake / proceed / bronchoscope-guided
  • intubation via SAD / front-of-neck airway)
  • |
  • v (Failed SAD Oxygenation)
  • [ PLAN C: Final Facemask Ventilation ]
  • Two-person technique with oropharyngeal/nasal airways
  • Ensure full neuromuscular block; prepare for FONA
  • |
  • v (Cannot Oxygenate: SpO2 falling)
  • [ PLAN D: CICO - Emergency Front of Neck Access ]
  • Declare CICO
  • SCALPEL - BOUGIE - TUBE Cricothyroidotomy
  • Plan A: Facemask Oxygenation and Tracheal Intubation

Optimize head positioning into the sniffing position (lower cervical flexion of about 35 ∘ 35^\circ 3 5 ∘ on the chest, with atlanto-occipital extension so that the plane of the face tilts back about 15 ∘ 15^\circ 1 5 ∘ from horizontal; in morbidly obese patients, align the external auditory meatus horizontally with the sternal notch by ramping ).

Use videolaryngoscopy: DAS 2025 states that it should be used for tracheal intubation because it improves first-pass success and reduces failed intubation compared with direct laryngoscopy.

Apply external laryngeal manipulation: BURP maneuver ( B ackward, U pward, R ightward P ressure on the thyroid cartilage) or bimanual laryngoscopy.

Employ a gum-elastic bougie (coudé tip): detect tactile "clicks" as the tip rubs against tracheal rings and "hold-up" at the carina ( 24 − 30 cm 24-30\text{ cm} 24 − 30 cm ). Absence of clicks or advancing beyond 35 cm 35\text{ cm} 35 cm without hold-up indicates esophageal misplacement.

Attempt Limit: Strict maximum of 3 attempts (one further attempt is permissible only by a more experienced colleague). Repeated attempts cause mucosal hemorrhage, laryngeal edema, and transform a "can ventilate" scenario into a catastrophic CICO crisis.

Plan B: Maintaining Oxygenation via Supraglottic Airway Device (SAD)

If Plan A fails, declare failed intubation and transition immediately to Plan B.

Insert a second-generation SAD (e.g., i-gel, ProSeal LMA, LMA Supreme). Second-generation devices feature an integrated gastric drainage port and provide higher airway seal pressures ( > 30 cmH 2 O >30\text{ cmH}_2\text{O} > 30 cmH 2 ​ O ).

Limit SAD insertion to a maximum of 3 attempts (adjusting size or depth).

If ventilation is successful via the SAD, STOP and THINK : 4 clinical options:

Awaken the patient (preferred for elective surgery).

Intubate through the SAD only under flexible bronchoscopic guidance (e.g., via an Aintree intubation catheter); blind intubation through a SAD is not recommended.

Proceed with the operation using the SAD (only in selected low-risk, emergency, or brief procedures).

Elective tracheostomy or surgical airway .

Plan C: Facemask Oxygenation and Awaken Patient

If Plan B fails, declare failed SAD oxygenation.

Attempt two-person bag-mask ventilation using an optimized technique: one clinician uses both hands to perform a vigorous jaw thrust with a two-handed "V-E" or "C-E" grip while a second clinician squeezes the reservoir bag.

Insert oral (Guedel) and nasopharyngeal airways.

Ensure Complete Neuromuscular Blockade: Administer a muscle relaxant or ensure full paralysis; flaccid vocal cords and relaxed thoracic musculature facilitate bag-mask ventilation.

If ventilation is restored: awaken the patient. Reverse neuromuscular blockade rapidly with sugammadex ( 16 mg/kg 16\text{ mg/kg} 16 mg/kg for immediate rocuronium reversal) or neostigmine/glycopyrrolate.

Plan D: Emergency Front of Neck Access (eFONA) in a CICO Crisis

If facemask oxygenation fails and hypoxemia ensues ( S p O 2 Sp\text{O}_2 Sp O 2 ​ rapidly declining), declare a Can't Intubate, Can't Oxygenate (CICO) crisis.

Call for immediate senior help, an emergency surgical airway kit, and prepare for immediate eFONA .

4. Emergency Front of Neck Access (eFONA): Scalpel-Bougie-Tube vs Needle Techniques

The UK 4th National Audit Project (NAP4) demonstrated that in CICO crises, needle cricothyroidotomy and transtracheal high-pressure jet ventilation suffered an alarming failure rate of > 60 % >60\% > 60% , frequently causing severe barotrauma, massive subcutaneous emphysema, pneumothorax, and patient death. Consequently, international guidelines mandate the scalpel-bougie-tube technique as the primary rescue modality. [ SCALPEL - BOUGIE - TUBE TECHNIQUE ]

  • Step 1: Identify Step 2: Vertical skin Step 3: Rotate 90° Step 4: Railroad
  • Cricothyroid cut, transverse stab & Insert Bougie Cuffed Tube
  • [Thyroid] [Thyroid] [Thyroid] [Thyroid]
  • || || || ||
  • === MEMBRANE === --- CUT --- -| TURN |- [ 6.0 ETT ]
  • || || || ||
  • [Cricoid] [Cricoid] [Cricoid] [Cricoid]
  • The DAS Scalpel-Bougie-Tube Technique

Positioning: Full neck extension (place a pillow or roll under the shoulders).

Identification: Perform the "laryngeal handshake" to identify the thyroid notch, cricoid cartilage, and the intervening cricothyroid membrane ( 9 − 10 mm 9-10\text{ mm} 9 − 10 mm high, 22 − 30 mm 22-30\text{ mm} 22 − 30 mm wide).

Incision:

DAS 2025 default: Make a vertical midline skin incision over the larynx (about 8 − 10 cm 8-10\text{ cm} 8 − 10 cm when the membrane is impalpable, as in obesity or haematoma), use blunt finger dissection to identify the cricothyroid membrane, then make a horizontal (transverse) stab incision through the membrane with a size 10 scalpel blade.

DAS 2015 approach: A single transverse stab through skin and membrane was used when the membrane was palpable, with the vertical incision reserved for an impalpable membrane.

Rotation: Turn the scalpel blade 90 ∘ 90^\circ 9 0 ∘ so that the blunt back of the blade rests against the thyroid cartilage and the sharp edge points caudally, widening the membrane opening.

Bougie Insertion: Slide a coudé-tip gum-elastic bougie along the flat surface of the scalpel blade into the trachea to a depth of 10 − 15 cm 10-15\text{ cm} 10 − 15 cm . Confirm tracheal entry by feeling tracheal clicks.

Railroading the Tube: Remove the scalpel. Railroad a cuffed 6.0 mm 6.0\text{ mm} 6.0 mm internal diameter tracheal tube over the bougie into the trachea. Inflate the cuff, verify end-tidal CO 2 \text{CO}_2 CO 2 ​ ( E t CO 2 Et\text{CO}_2 Et CO 2 ​ ) capnography, and secure the tube.

Why Scalpel-Bougie-Tube is Superior to Needle Techniques:

Uses standard equipment present in every operating room.

Does not rely on high-pressure jet ventilators (which generate 2 − 4 bar 2-4\text{ bar} 2 − 4 bar pressures and cause tension pneumothorax if exhalation through the upper airway is obstructed).

Establishes a definitive cuffed conduit allowing normal low-pressure tidal ventilation and capnography monitoring.

5. Awake Tracheal Intubation (ATI)

Awake Tracheal Intubation (ATI)—typically performed with a flexible bronchoscope or videolaryngoscope—is the gold standard whenever significant difficulty with both intubation and ventilation is anticipated (e.g., severe micrognathia, glottic tumor, Ludwig's angina, unstable cervical spine fracture, morbid ankylosing spondylitis).

Stepwise Protocol for ATI

Informed Consent and Psychological Preparation: Comprehensive explanation reduces patient anxiety and blunts hypertensive surges.

Antisialogogue Administration: Administer glycopyrrolate 0.2 mg 0.2\text{ mg} 0.2 mg IV 15 − 30 minutes 15-30\text{ minutes} 15 − 30 minutes prior to the procedure. Drying mucosal secretions is critical to allow topical local anaesthetic absorption and preserve clear optical views through the bronchoscope.

Airway Topicalization with Lidocaine:

Safe Dosage Limits: The maximum safe topical dose of lidocaine is 9 mg/kg 9\text{ mg/kg} 9 mg/kg of lean body weight (rapid systemic absorption occurs across vascular tracheal and bronchial mucosae).

Delivery Methods: Mucosal Atomization Devices (MAD), 2% lidocaine viscous gargles, nebulized 4% lidocaine, and the "spray-as-you-go" technique using 2 mL 2\text{ mL} 2 mL aliquots of 2% lidocaine instilled directly through the working channel of the bronchoscope onto the vocal cords and subglottic mucosa.

Regional Airway Nerve Blocks (Optional Adjuncts):

Glossopharyngeal Nerve Block: Blocks sensory innervation to the posterior third of the tongue, vallecula, and anterior surface of the epiglottis. Performed by injecting 2 mL 2\text{ mL} 2 mL of 2% lidocaine submucosally at the base of the posterior tonsillar pillar (aspirating to prevent accidental internal carotid artery injection).

Superior Laryngeal Nerve Block (Internal Branch): Blocks sensory innervation to the larynx above the vocal cords (vallecula, epiglottis, aryepiglottic folds). Performed by injecting 2 mL 2\text{ mL} 2 mL of 2% lidocaine at the greater horn of the hyoid bone.

Transtracheal Injection (Recurrent Laryngeal Nerve Mucosal Block): A needle penetrates the cricothyroid membrane; after air aspiration confirms tracheal placement, 3 − 4 mL 3-4\text{ mL} 3 − 4 mL of 2% or 4% lidocaine is rapidly injected. The patient coughs, forcefully atomizing lidocaine over the true vocal cords and trachea.

Conscious Sedation: Pharmacotherapy must maintain spontaneous ventilation, airway reflexes, and patient cooperation. Preferred regimens:

Remifentanil Target-Controlled Infusion (TCI): Target effect-site concentration of 1.5 − 3.0 ng/mL 1.5-3.0\text{ ng/mL} 1.5 − 3.0 ng/mL ; provides profound analgesia and cough suppression with rapid offset.

Dexmedetomidine Infusion: Selective α 2 \alpha_2 α 2 ​ -agonist (loading dose 0.5 − 1.0 μ g/kg 0.5-1.0\text{ }\mu\text{g/kg} 0.5 − 1.0 μ g/kg over 10 minutes 10\text{ minutes} 10 minutes , maintenance 0.4 − 0.7 μ g/kg/h 0.4-0.7\text{ }\mu\text{g/kg/h} 0.4 − 0.7 μ g/kg/h ). Provides "cooperative sedation" without respiratory depression.

Tracheal Tube Insertion: Once the bronchoscope visualizes the tracheal carina, advance the pre-loaded tracheal tube into the mid-trachea using a gentle clockwise twisting motion (preventing the tube bevel from catching on the right arytenoid cartilage). Confirm positioning, inflate the cuff, confirm end-tidal CO 2 \text{CO}_2 CO 2 ​ , and induce general anaesthesia.